Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | HRH2 | P25021 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19600462 | 0.89 | ALDH1A1 (0.53) | ALDH1A1KMT2AMEN1L3MBTL1HDAC3 | |
| SCHEMBL27421358 | 0.80 | CTSK (0.41) | ALDH1A1KMT2AMEN1L3MBTL1HDAC3 | |
| SCHEMBL15499765 | 0.79 | ALDH1A1 (0.56) | ALDH1A1KMT2AMEN1L3MBTL1SMN1; SMN2 | |
| SCHEMBL27402975 | 0.79 | HDAC3 (0.50) | ALDH1A1KMT2AL3MBTL1HDAC3HDAC1 | |
| SCHEMBL17721364 | 0.78 | MEN1 (0.57) | ALDH1A1KMT2AMEN1L3MBTL1SMN1; SMN2 | |
| SCHEMBL11491096 | 0.78 | ALDH1A1 (0.47) | ALDH1A1KMT2AMEN1HDAC3HDAC1 | |
| SCHEMBL11477434 | 0.78 | ALDH1A1 (0.47) | ALDH1A1KMT2AMEN1HDAC3HDAC1 | |
| SCHEMBL11479562 | 0.78 | ALDH1A1 (0.47) | ALDH1A1KMT2AMEN1HDAC3HDAC1 | |
| SCHEMBL24760258 | 0.77 | ACHE (0.44) | ALDH1A1KMT2AMEN1L3MBTL1HDAC3 | |
| Bromide SCHEMBL11476767 | 0.77 | ALDH1A1 (0.46) | ALDH1A1KMT2AMEN1HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170290920-A1 | ANTI-CD22 ANTIBODIES AND IMMUNOCONJUGATES | MEDIMMUNE LIMITED (GB) | 2017-10-12 | — | — | US | disclosed |
| US-20170002085-A1 | METHODS OF USING ANTI-LGR5 ANTIBODIES | GENENTECH, INC. (US) | 2017-01-05 | — | — | US | disclosed |
| US-9464141-B2 | Anti-ETBR antibodies and immunoconjugates | GENENTECH, INC. (US) | 2016-10-11 | — | — | US | disclosed |
| US-9463251-B2 | Anti-ETBR antibodies and immunoconjugates | GENENTECH, INC. (US) | 2016-10-11 | — | — | US | disclosed |
| US-20160102146-A1 | ANTI-LGR5 ANTIBODIES AND IMMUNOCONJUGATES | GENENTECH, INC. (US) | 2016-04-14 | — | — | US | disclosed |
| US-9175089-B2 | Anti-LGR5 antibodies and immunoconjugates | GENENTECH, INC. (US) | 2015-11-03 | — | — | US | disclosed |
| US-20150196660-A1 | ANTI-ETBR ANTIBODIES AND IMMUNOCONJUGATES | GENENTECH INC (US) | 2015-07-16 | — | — | US | disclosed |
| US-20150183883-A1 | ANTI-ETBR ANTIBODIES AND IMMUNOCONJUGATES | GENENTECH INC (US) | 2015-07-02 | — | — | US | disclosed |
| US-20150098900-A1 | ANTI-FCRH5 ANTIBODIES | GENENTECH, INC | 2015-04-09 | — | — | US | disclosed |
| US-20140030282-A1 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES | GENENTECH, INC. (US) | 2014-01-30 | — | — | US | disclosed |
| US-20140030281-A1 | ANTI-CD22 ANTIBODIES AND IMMUNOCONJUGATES | GENENTECH, INC. (US) | 2014-01-30 | — | — | US | disclosed |
| US-20140030280-A1 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES | GENENTECH, INC. (US) | 2014-01-30 | — | — | US | disclosed |
| US-20140030279-A1 | ANTI-CD22 ANTIBODIES AND IMMUNOCONJUGATES | SPIROGEN SARL (CH) | 2014-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140030281-A1 | ANTI-CD22 ANTIBODIES AND IMMUNOCONJUGATES | CD22, CD2, CD2BP2 | ALDH1A1 260/4885KMT2A 2029/4885MEN1 3769/4885 |
| US-20170002085-A1 | METHODS OF USING ANTI-LGR5 ANTIBODIES | SHH, SMO, GLI1 | ALDH1A1 1127/4885KMT2A 2721/4885MEN1 1225/4885 |
| US-20160102146-A1 | ANTI-LGR5 ANTIBODIES AND IMMUNOCONJUGATES | EPCAM, CD44, CD63 | ALDH1A1 621/4885KMT2A 2176/4885MEN1 977/4885 |
| US-20150098900-A1 | ANTI-FCRH5 ANTIBODIES | FCGR3B, FCGRT, FCGR1A | ALDH1A1 2977/4885KMT2A 2793/4885MEN1 4003/4885 |
| US-20150196660-A1 | ANTI-ETBR ANTIBODIES AND IMMUNOCONJUGATES | ETV6, CTCF, EWSR1 | ALDH1A1 2535/4885KMT2A 323/4885MEN1 4113/4885 |
| US-20170290920-A1 | ANTI-CD22 ANTIBODIES AND IMMUNOCONJUGATES | CD22, CD2, CD2BP2 | ALDH1A1 260/4885KMT2A 2029/4885MEN1 3769/4885 |
| US-20140030280-A1 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES | CD79B, CD99, CD47 | ALDH1A1 2396/4885KMT2A 1293/4885MEN1 3512/4885 |
| US-20140030282-A1 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES | CD79B, CD99, CD47 | ALDH1A1 2396/4885KMT2A 1293/4885MEN1 3512/4885 |
| US-20150183883-A1 | ANTI-ETBR ANTIBODIES AND IMMUNOCONJUGATES | CTCF, EDNRB, ETV6 | ALDH1A1 1922/4885KMT2A 265/4885MEN1 4135/4885 |
| US-20140030279-A1 | ANTI-CD22 ANTIBODIES AND IMMUNOCONJUGATES | CD22, CD2, CD2BP2 | ALDH1A1 260/4885KMT2A 2029/4885MEN1 3769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.